RESUMO
BACKGROUND: Since 2015 operations performed in the field of endocrine surgery have been entered into the European registry EUROCRINE®. The aim of this analysis was a description of the current healthcare situation for adrenal surgery in a homogeneous healthcare environment corresponding to the German-speaking countries-or to the presence of the working group on surgical endocrinology (CAEK) of the German society for general and visceral surgery (DGAV)-and to assess the adherence to current international treatment guidelines. METHODS: An analysis of the preoperative diagnostics, the applied operative techniques and the underlying histological entities was carried out for all operations on adrenal glands in Germany, Switzerland and Austria, which were registered in EUROCRINE® from 2015 to 2019. RESULTS: In the total of 21 participating hospitals from the German-speaking EUROCRINE® countries, 658 operations on adrenal glands were performed. In 90% of cases unilateral adrenalectomy was performed, in 3% bilateral adrenalectomy and in 7% other resection procedures. In 41% the main histological diagnosis was an adrenocortical adenoma. In 15% malignant entities were detected on final histology, including 6% adrenocortical carcinoma (ACC) and 8% metastases to the adrenal glands. 23% of the operations were performed for pheochromocytoma. This entity was primarily resected using minimally invasive approaches (82%), whereas minimally invasive techniques were applied in 28% for ACC and in 66% for metastases to the adrenal glands. CONCLUSION: Surprisingly, following adrenocortical adenoma and pheochromocytoma, the third most common histological entity was metastasis of different extra-adrenal primary tumors to the adrenal gland. Of the operations for ACC 28% were scheduled for minimally invasive techniques, but conversion to open surgery was necessary in 20%. The analysis revealed discrepancies between treatment reality and international guideline recommendations that raise questions, which will be addressed by an updated version of the EUROCRINE® module for the documentation of adrenal surgery.
Assuntos
Neoplasias do Córtex Suprarrenal , Neoplasias das Glândulas Suprarrenais , Laparoscopia , Neoplasias do Córtex Suprarrenal/cirurgia , Neoplasias das Glândulas Suprarrenais/cirurgia , Adrenalectomia , Áustria , Alemanha , Humanos , SuíçaRESUMO
Bulky and hyphenated laboratory-based analytical instrumentation such as gas chromatography/mass spectrometry is still required to trace breath biomarkers in the low ppbV level. Innovative sensor-based technologies could provide on-site and point-of-care (POC) detection of volatile biomarkers such as breath aldehydes related to oxidative stress and cancer. An electrochemical sensor system was developed for direct detection of the total abundance of aldehydes in exhaled breath in the ppbV level and for simultaneous determination of the airway inflammation markers carbon monoxide (CO) and nitric oxide (NO). The sensor system was tested in vitro with gaseous standard mixtures and in vivo in spontaneously breathing patients and under mechanical ventilation in an animal model. The sensor system provided in vitro and in vivo detection of trace levels of aldehydes, CO and NO. Inertness of the tubing system was important for reliable results. Sensitivity of the aldehyde sensor increased with humidity. Response time for analysis of breath samples was about 22 s and relative standard deviations of sensor amplitudes were <5%. Detection limits in the low ppbV range and a linear range of more than two orders of magnitude could be achieved for volatile aldehydes. Cross sensitivities were moderate for alcohols such as ethanol or isopropanol and negligible for other typical breath volatile organic compounds such as acetone, isoprene or propofol. In proof of concept analyses in patients suffering from lung cancer and diabetes, aldehyde and CO sensor signals differed between the groups. Elevated CO levels indicated previous smoking. In a mechanically ventilated pig, continuous monitoring of breath aldehyde concentrations in the low ppbV was realized. Cumulative aldehyde measurements may add interesting and complementary information to the conventional parameters used in clinical breath research. POC applicability, easy handling and low cost of sensors facilitate measurements in large patient cohorts.
Assuntos
Biomarcadores/análise , Testes Respiratórios/instrumentação , Compostos Orgânicos Voláteis/análise , Aldeídos/análise , Animais , Monóxido de Carbono/análise , Eletroquímica/instrumentação , Desenho de Equipamento , Expiração/fisiologia , Feminino , Cromatografia Gasosa-Espectrometria de Massas/instrumentação , Humanos , Neoplasias Pulmonares/diagnóstico , Masculino , Modelos Animais , Monitorização Intraoperatória/instrumentação , Óxido Nítrico/análise , Sistemas Automatizados de Assistência Junto ao Leito , Valor Preditivo dos Testes , SuínosAssuntos
Antibacterianos/farmacologia , DNA Nucleotidiltransferases/metabolismo , RNA Polimerases Dirigidas por DNA/metabolismo , Oligopeptídeos/farmacologia , Pirróis/farmacologia , DNA Polimerase Dirigida por RNA/metabolismo , Trifosfato de Adenosina , Amidinas/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , DNA , Escherichia coli/enzimologia , Peixes , Leucemia Linfoide/metabolismo , Masculino , Camundongos , Micrococcus/enzimologia , RNA , Vírus Rauscher/enzimologia , Especificidade da Espécie , Espermatozoides , Relação Estrutura-Atividade , Moldes Genéticos , Trítio , Nucleotídeos de UracilaRESUMO
Praziquantel, a new anthelmintic drug with activity against all species of schistosomes pathogenic to man, and against a wide range of Cestodes, was tested for mutagenic potential. For the detection of both base substitutions and frameshift mutations, Salmonella typhimurium TA 100 and TA 98 were used as tester strains. Using the plate assay with and without added S-9, host-mediated assay and urine-mediated assay without and after incubation with beta-glucuronidase/arylsulfatase, no mutagenic activity could be detected.
Assuntos
Anti-Helmínticos , Isoquinolinas/farmacologia , Mutagênicos , Mutação/efeitos dos fármacos , Administração Oral , Animais , Anti-Helmínticos/administração & dosagem , Anti-Helmínticos/uso terapêutico , Humanos , Isoquinolinas/uso terapêutico , Camundongos , Camundongos Endogâmicos , Fatores R , Ratos , Salmonella typhimurium/efeitos dos fármacos , Schistosoma/efeitos dos fármacos , Esquistossomose/tratamento farmacológicoRESUMO
Preclinical in vitro assessment of highly purified natural human interleukin-2 (IL-2) packed in egg lecithin liposomes was performed in short- and long-term T-cell cloning and propagation systems, and in experiments testing induction of lymphokine-activated killer (LAK) cells. Liposomal IL-2 (lip-IL-2) was essentially as active as free natural or recombinant IL-2 for cloning and culture of both helper and cytotoxic alloreactive T cells. However, lip-IL-2 was found to be markedly inferior to free natural or recombinant IL-2 for the induction of LAK cells from normal donors. Nevertheless, lip-IL-2 was able to maintain LAK cytotoxicity of populations preactivated with free IL-2. These results suggest that lip-IL-2 can interact with activated T cells and LAK cells in the same way as free IL-2, but that it is much less efficient at activating LAK-cell precursors.
Assuntos
Interleucina-2/administração & dosagem , Humanos , Técnicas In Vitro , Células Matadoras Ativadas por Linfocina/imunologia , Lipossomos , Ativação Linfocitária , Linfócitos T/imunologiaRESUMO
The agents daunomycin, ethidium bromide, distamycin A and cytochrome c inhibit DNA dependent DNA polymerase I (E. coli) reaction competitively to DNA. The influence of these template inactivators on the binding of DNA polymerase to native as well as denatured DNA has been determined by affinity chromatography. Cytochrome c blocks the binding of the enzyme to double-stranded and to single-stranded DNA Sepharose. In contrast to these results daunomycin, ethidium bromide or distamycin A reduce the binding affinity only with denatured DNA Sepharose as matrix. These data are discussed with respect to the modification by template inactivators of the affinity of DNA to the different binding sites of the DNA polymerase.
Assuntos
DNA Polimerase I/metabolismo , DNA/metabolismo , Animais , Sítios de Ligação , Grupo dos Citocromos c/farmacologia , DNA/química , DNA Polimerase I/antagonistas & inibidores , Daunorrubicina/farmacologia , Distamicinas/farmacologia , Inibidores Enzimáticos/farmacologia , Etídio/farmacologia , Técnicas In Vitro , Cinética , MasculinoRESUMO
THE ACTIVITIES OF THE FOLLOWING ENZYMES HAVE BEEN DETERMINED IN NUCLEI OF QUAIL OVIDUCTS IN RESPONSE TO EXOGENOUS STIMULATION OF THE BIRDS WITH DIETHYLSTILBESTROL, USED AS AN ESTROGEN ANALOGUE AND PROGESTERONE: DNA dependent DNA polymerase, DNA dependent RNA polymerase I and II and poly(adenosine diphosphate-ribose) [=poly(ADP-Rib)] polymerase.During primary stimulation with the estrogen analogue the activities of the four DNA dependent polymerases increase to about the same degree. Upon withdrawal of the hormones the levels of the enzymes drop to values known from nuclei from unstimulated quail oviducts. The secondary stimulation with the estrogen analogue causes a significant increase only of the RNA polymerase II. The in vivo induction of avidin by progesterone in oviduct mucosa cells from quails, during the period of primary estrogen stimulation, is accompanied by an increase of RNA polymerase II activity and a marked decrease of poly(ADP-Rib) polymerase activity. The activities of RNA polymerase I and of poly(ADP-Rib) polymerase are not affected significantly by an exogenous administration of progesterone.
Assuntos
Coturnix/metabolismo , Oviductos/enzimologia , Poli(ADP-Ribose) Polimerases/análise , Animais , Avidina/biossíntese , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , DNA Polimerase Dirigida por DNA/metabolismo , Dietilestilbestrol/farmacologia , Indução Enzimática/efeitos dos fármacos , Feminino , NAD/metabolismo , Oviductos/efeitos dos fármacos , Progesterona/farmacologia , RNA Polimerase I/metabolismo , RNA Polimerase II/metabolismoRESUMO
It was the aim of this study to investigate the antileukemic activities of recombinant interferon beta (rIFN beta) in chronic-phase CML in vitro and in vivo. Nine patients in the early chronic-phase of CML were treated in a phase-II trial with escalating doses of rIFN beta. In parallel, antiproliferative and immunomodulatory activities of rIFN beta and rIFN alpha 2b were studied in vitro. rIFN beta exhibited a significantly higher antiproliferative activity on hematopoietic progenitor cells of CML patients in vitro than rIFN alpha 2b. In contrast, only very limited clinical antileukemic efficacy of rIFN beta was observed. None of the patients achieved a complete or partial hematologic response (0% response rate, 0-36% 95 C.I.). Primary resistance of CML patients to rIFN beta treatment was caused neither by antibody formation against the recombinant material nor by deficient IFN receptor targeting and/or signaling; Induction of serum levels of beta-2-microglobulin (beta-2-m) and neopterin after administration of rIFN beta was comparable to that seen after administration of rIFN alpha. However, rIFN beta treatment less effectively induced biosynthesis of interleukin-1 receptor antagonist protein (IL-1-Ra) than rIFN alpha 2b. Thus, we conclude that rIFN beta at doses up to 12 MU/day s.c. is ineffective for treatment of chronic-phase CML. Further investigations into divergent biologic responses to various type-I interferons might help to elucidate mechanisms crucial for IFN action in patients with CML.